Security key
00972D105
Akebia Therapeutics, Inc. - COMMON STOCK (AKBA)
CUSIP: 00972D105
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 270,093,163
- Total 13F shares
- 95,246,755
- Share change
- +33,000,297
- Total reported value
- $182,865,666
- Put/Call ratio
- 324%
- Price per share
- $1.92
- Number of holders
- 142
- Value change
- +$63,362,812
- Number of buys
- 91
- Number of sells
- 29
Report period
Q1 2025
Institutions
142
Top holders
10
AKBA full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Akebia Therapeutics, Inc. SEC filings
Akebia Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00972D105
Recent filing periods:
Top shareholders of AKBA - Akebia Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Muneer A. Satter |
13D/G
|
Satter Muneer A |
2.6%
|
5,747,906
|
$13,105,226 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
5.6%
|
15,097,625
|
$28,685,488 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4%
|
10,884,200
|
$20,679,981 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
6,304,698
|
$11,978,926 | — | 31 Dec 2024 | |
| Alerce Investment Management, L.P. |
13F
|
Company |
2.1%
|
5,747,906
|
$10,921,021 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
4,795,095
|
$9,112,359 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.4%
|
3,823,527
|
$7,264,701 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.66%
|
1,790,051
|
$3,401,097 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.62%
|
1,685,641
|
$3,202,718 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.51%
|
1,382,146
|
$2,626,077 | — | 31 Dec 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.45%
|
1,228,710
|
$2,334,549 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.44%
|
1,191,359
|
$2,263,582 | — | 31 Dec 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.38%
|
1,026,896
|
$1,951,102 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.37%
|
1,002,194
|
$1,904,169 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.34%
|
914,003
|
$1,736,605 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.28%
|
747,006
|
$1,419,312 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.22%
|
586,710
|
$1,114,749 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.22%
|
586,097
|
$1,113,584 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.2%
|
543,916
|
$1,033,441 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.19%
|
502,127
|
$954,042 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
497,547
|
$945,340 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.17%
|
456,294
|
$866,959 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.14%
|
380,535
|
$723,016 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.14%
|
375,495
|
$713,441 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
351,091
|
$667,073 | — | 31 Dec 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.1%
|
274,452
|
$521,459 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
265,389
|
$504,233 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.09%
|
236,786
|
$449,894 | — | 31 Dec 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.08%
|
205,956
|
$391,316 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.07%
|
202,275
|
$384,322 | — | 31 Dec 2024 | |
| SAPIENT CAPITAL LLC |
13F
|
Company |
0.07%
|
200,000
|
$380,000 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
181,048
|
$343,991 | — | 31 Dec 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.07%
|
179,752
|
$341,529 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.06%
|
169,647
|
$322,329 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.06%
|
167,184
|
$317,650 | — | 31 Dec 2024 | |
| Creative Planning |
13F
|
Company |
0.06%
|
166,303
|
$315,976 | — | 31 Dec 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.06%
|
156,462
|
$297,278 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.05%
|
143,149
|
$271,983 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.05%
|
137,905
|
$263,000 | — | 31 Dec 2024 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.05%
|
135,392
|
$257,245 | — | 31 Dec 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.05%
|
128,982
|
$245,000 | — | 31 Dec 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.05%
|
126,380
|
$239,766 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.05%
|
125,680
|
$238,792 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
122,397
|
$232,554 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.04%
|
120,646
|
$229,228 | — | 31 Dec 2024 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.04%
|
118,209
|
$224,597 | — | 31 Dec 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.04%
|
116,771
|
$222,000 | — | 31 Dec 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.04%
|
110,930
|
$210,766 | — | 31 Dec 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.04%
|
104,030
|
$197,657 | — | 31 Dec 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.04%
|
103,422
|
$196,502 | — | 31 Dec 2024 |
Institutional Holders of Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) as of Q1 2025
As of 31 Mar 2025,
Akebia Therapeutics, Inc. - COMMON STOCK (AKBA) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,246,755 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, GREAT POINT PARTNERS LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, AIGH Capital Management LLC, GOLDMAN SACHS GROUP INC, and MORGAN STANLEY.
This page lists
142
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
120
Q1 2025 holders
142
Holder diff
22
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.